Anika Therapeutics (ANIK) Cash from Investing Activities (QoQ) (2010 - 2026)
Anika Therapeutics (ANIK) Cash from Investing Activities (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.23 Bn | 19.57 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.47 Bn | 15.08 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Anika Therapeutics | 286.33 Mn | 247.92 Mn | 21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.31% |
| Mar 31, 2026 | -725.76% |
| Dec 31, 2025 | 111.43% |
| Sep 30, 2025 | -221.34% |
| Jun 30, 2025 | -132.24% |
| Mar 31, 2025 | 227.93% |
| Dec 31, 2024 | 28.03% |
| Sep 30, 2024 | 46.64% |
| Jun 30, 2024 | -88.22% |
| Mar 31, 2024 | 1.74% |
| Dec 31, 2023 | -148.31% |
| Sep 30, 2023 | 49.14% |
| Jun 30, 2023 | -4.90% |
| Mar 31, 2023 | 45.08% |
| Dec 31, 2022 | -49.56% |
| Sep 30, 2022 | 12.84% |
| Jun 30, 2022 | -46.30% |
| Mar 31, 2022 | -6.94% |
| Dec 31, 2021 | 4.25% |
| Sep 30, 2021 | 44.11% |